• Tue / 7 May 2019 / 12:30
  • Category: Science
  • News Code: 98021709125
  • Journalist : 71593

Iran joined three countries producing anti-diabetes medicine

Iran joined three countries producing anti-diabetes medicine

Tehran (ISNA) – Two new medicines for diabetes treatment were unveiled by an Iranian knowledge-based company, with Science and Technology Vice-President and Health Minister in attendance.

The anti-diabetes medicine “Empagliflozin” reduces adults’ death rate caused by type 2 diabetes.

United States and Germany were the only countries possessing the technical knowledge to produce the medicine and Iran is now the third country able to produce Empagliflozin.

“Dapagliflozin” is another new medicine for non-insulin-dependent diabetes that Iran is now producing, after United Kingdom.

The drugs are classified as inhibitors of the sodium glucose co-transporter-2 (SGLT-2).

The two medicines have initially been released in market in 2014 and Iran could localize the drugs after five years in 2019.

End Item

  • در زمینه انتشار نظرات مخاطبان رعایت چند مورد ضروری است:
  • -لطفا نظرات خود را با حروف فارسی تایپ کنید.
  • -«ایسنا» مجاز به ویرایش ادبی نظرات مخاطبان است.
  • - ایسنا از انتشار نظراتی که حاوی مطالب کذب، توهین یا بی‌احترامی به اشخاص، قومیت‌ها، عقاید دیگران، موارد مغایر با قوانین کشور و آموزه‌های دین مبین اسلام باشد معذور است.
  • - نظرات پس از تأیید مدیر بخش مربوطه منتشر می‌شود.


You are replying to: .